Search
for
Sort by
Research 30 of 1000+
- Oral contraceptives and risk of breast cancer in women aged 20–54 years
- Hair relaxer use and breast cancer risk by tumor molecular subtypes.
- Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis
- Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- 61537 No Increased Risk of Breast or Gynecologic Cancers in Women with 5α-Reductase Inhibitor Exposure for Female Pattern Hair Loss: A Population-Based Propensity Score-Matched Cohort Study
- Spironolactone use and the risk of breast cancer
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Systematic Review of the Risk of Permanent Alopecia with Docetaxel Treatment for Breast Cancer
- Could the use of personal care oils in black women contribute to recent findings of an increased risk of breast cancer in this population?
- The Black identity, hair product use, and breast cancer scale
- A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Male alopecia, finasteride, and cancer risk
- Risk of Estrogen-Driven Malignancies in Females on 5-alpha Reductase Inhibitors
- Contraception hormonale et cancer du sein : Une question de contexte
- Spironolactone and breast cancer: Fear not!
- Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries
- Exploring the historical stigma of spironolactone use in breast cancer survivors with alopecia
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Breast cancer in a transgender man
- Association of breast and colorectal cancer in patients with central centrifugal cicatricial alopecia: A retrospective, cross-sectional pilot study
- FEMALE BREAST CANCER PROTECTION USING PHYTOESTROGEN LIGNANS FROM FLAXSEED
- Clinical and genetic predictors of persistent chemotherapy-induced alopecia despite scalp cooling in breast cancer